/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Disease, Please
4.9.20, 10:41 AM EDT on neoscope
Terrifying Simulation Shows How Viruses Spread When You Cough
Deadly Cocktail
4.8.20, 5:09 PM EDT on neoscope
The Coronavirus Is Deadlier in Places With Bad Pollution
Just Wave
Updated 4.8.20, 3:00 PM EDT on neoscope
Dr. Fauci: "I Don't Think We Should Ever Shake Hands Ever Again"
Buck Passing
Updated 4.8.20, 12:49 PM EDT on neoscope
Trump Threatens to Pull Funding for the World Health Organization
Systematic Inequa...
4.8.20, 11:35 AM EDT on neoscope
The Coronavirus Is Disproportionately Killing Black People
Personal Interests
4.7.20, 5:07 PM EDT on neoscope
There's No Good Evidence That Hydroxychloroquine Fights COVID-19
Today in Absolute...
4.7.20, 1:45 PM EDT on neoscope
Many COVID-19 Patients Are Dying from Cardiac Arrest
Race for a Vaccine
4.7.20, 10:21 AM EDT on neoscope
Volunteers Start Taking Another Experimental Coronavirus Vaccine
First World Leader
4.6.20, 3:35 PM EDT on neoscope
Breaking: British Prime Minister With COVID-19 Moved to ICU
Round Two
4.6.20, 1:30 PM EDT on neoscope
Hong Kong, Taiwan Face New COVID Outbreaks From Europe, America
Bad Actors
4.6.20, 12:00 PM EDT on neoscope
Scammers Dressed as Doctors Set Up Fake COVID Testing Sites
Fighting the Virus
Updated 4.3.20, 8:35 PM EDT on neoscope
Anti-Parasitic Drug Kills Coronavirus Cell Cultures in 48 Hours
  • Previous
  • 1
  • ...
  • 180
  • 181
  • 182
  • ...
  • 216
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.